{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:31:17Z","timestamp":1794958277175,"version":"4.9.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1213\/01.ane.0000194447.46763.73","type":"journal-article","created":{"date-parts":[[2006,1,16]],"date-time":"2006-01-16T04:00:55Z","timestamp":1137384055000},"page":"509-516","source":"Crossref","is-referenced-by-count":60,"title":["A Lack of Antinociceptive or Antiinflammatory Effect of Botulinum Toxin A in an Inflammatory Human Pain Model"],"prefix":"10.1213","volume":"102","author":[{"given":"Thomas","family":"Sycha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Samal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Chizh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Lehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Gustorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schnider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Auff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-35-20210902","doi-asserted-by":"crossref","first-page":"I19","DOI":"10.1007\/s00415-004-1106-8","article-title":"Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.","volume":"251","author":"Sycha","year":"2004","journal-title":"J Neurol"},{"key":"R2-35-20210902","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3959(01)00292-5","article-title":"Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes.","volume":"91","author":"G\u00f6bel","year":"2001","journal-title":"Pain"},{"key":"R3-35-20210902","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.870020402","article-title":"Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.","volume":"2","author":"Brin","year":"1987","journal-title":"Mov Disord"},{"key":"R4-35-20210902","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1526-4610.2000.00044.x","article-title":"Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study.","volume":"40","author":"Rollnik","year":"2000","journal-title":"Headache"},{"key":"R5-35-20210902","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s101940200024","article-title":"Physical therapy and adjunctive botulinum toxin type A in the treatment of cervical headache: a double-blind, randomised, placebo-controlled study.","volume":"3","author":"Schnider","year":"2002","journal-title":"J Headache Pain"},{"key":"R6-35-20210902","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1468-2982.2002.00390.x","article-title":"Treatment of headache with botulinum toxin A: a review according to evidence-based medicine criteria.","volume":"22","author":"Evers","year":"2002","journal-title":"Cephalalgia"},{"key":"R7-35-20210902","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pain.2004.01.016","article-title":"Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.","volume":"109","author":"Schulte-Mattler","year":"2004","journal-title":"Pain"},{"key":"R8-35-20210902","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-510X(02)00313-1","article-title":"Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study.","volume":"205","author":"Blersch","year":"2002","journal-title":"J Neurol Sci"},{"key":"R9-35-20210902","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00415-003-0971-x","article-title":"Botulinum toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.","volume":"250","author":"Kr\u00e4mer","year":"2003","journal-title":"J Neurol"},{"key":"R10-35-20210902","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1212\/01.WNL.0000086374.92906.6A","article-title":"A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A.","volume":"61","author":"Voller","year":"2003","journal-title":"Neurology"},{"key":"R11-35-20210902","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain.","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"key":"R12-35-20210902","doi-asserted-by":"crossref","first-page":"542S","DOI":"10.1042\/bst025542s","article-title":"Capsaicin stimulates release of substance P from dorsal root ganglion neurons via two distinct mechanisms.","volume":"25","author":"Purkiss","year":"1997","journal-title":"Biochem Soc Trans"},{"key":"R13-35-20210902","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","article-title":"Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.","volume":"38","author":"Welch","year":"2000","journal-title":"Toxicon"},{"key":"R14-35-20210902","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0304-3959(98)00062-1","article-title":"Effects of antihyperalgesic drugs on experimentally induced hyperalgesia in mean.","volume":"76","author":"Bickel","year":"1998","journal-title":"Pain"},{"key":"R15-35-20210902","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.0306-5251.2003.01869.x","article-title":"A simple pain model for the evaluation of analgesic effects of NSAIDs in healthy subjects.","volume":"56","author":"Sycha","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"R16-35-20210902","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1213\/01.ANE.0000095150.76735.5D","article-title":"The effects of remifentanil and gabapentin on hyperalgesia in a new extended inflammatory skin pain model in healthy volunteers.","volume":"98","author":"Gustorff","year":"2004","journal-title":"Anesth Analg"},{"key":"R17-35-20210902","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.pain.2004.11.002","article-title":"Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: a randomized, double blinded, placebo controlled crossover trial in the UV-B pain model.","volume":"113","author":"Sycha","year":"2005","journal-title":"Pain"},{"key":"R18-35-20210902","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1213\/01.ANE.0000093224.77281.A5","article-title":"The sunburn pain model: the stability of primary and secondary hyperalgesia over 10 hours in a crossover setting.","volume":"98","author":"Gustorff","year":"2004","journal-title":"Anesth Analg"},{"key":"R19-35-20210902","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0304-3959(94)00132-X","article-title":"Heat pain thresholds: normative data and repeatability.","volume":"60","author":"Yarnitsky","year":"1995","journal-title":"Pain"},{"key":"R20-35-20210902","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/122.12.2245","article-title":"Secondary hyperalgesia to punctate mechanical stimuli: central sensitization to A-fibre nociceptor input.","volume":"122","author":"Ziegler","year":"1999","journal-title":"Brain"},{"key":"R21-35-20210902","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0304-3959(01)00438-9","article-title":"Neurogenic hyperalgesia versus painful hypoalgesia: two distinct mechanisms of neuropathic pain.","volume":"96","author":"Baumgartner","year":"2002","journal-title":"Pain"},{"key":"R22-35-20210902","first-page":"302","article-title":"Ein neues verfahren zur klinischen untersuchung der schweissabsonderung.","volume":"101","author":"Minor","year":"1927","journal-title":"Z Neurol"},{"key":"R23-35-20210902","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1054\/jocn.2000.0684","article-title":"The current use of botulinum toxin.","volume":"7","author":"Mahant","year":"2000","journal-title":"J Clin Neurosci"},{"key":"R24-35-20210902","doi-asserted-by":"crossref","first-page":"21338","DOI":"10.1016\/S0021-9258(19)36614-1","article-title":"Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes: clues to the locus of action.","volume":"267","author":"McMahon","year":"1992","journal-title":"J Biol Chem"},{"key":"R25-35-20210902","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1471-4892(01)00002-9","article-title":"Peripheral excitatory amino acids.","volume":"1","author":"Carlton","year":"2001","journal-title":"Curr Opin Pharmacol"},{"key":"R26-35-20210902","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00726-001-0124-4","article-title":"Novel approaches to targeting glutamate receptors for the treatment of chronic pain: review article.","volume":"23","author":"Chizh","year":"2002","journal-title":"Amino Acids"},{"key":"R27-35-20210902","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1073\/pnas.85.20.7820","article-title":"Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord.","volume":"85","author":"De Biasi","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-35-20210902","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-0597-0","article-title":"Sensory mechanisms of the spinal cord.","author":"Willis","year":"1991"},{"key":"R29-35-20210902","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(97)00494-1","article-title":"Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis.","volume":"230","author":"Schmelz","year":"1997","journal-title":"Neurosci Lett"},{"key":"R30-35-20210902","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1469-7793.2000.00803.x","article-title":"Electrically evoked neuropeptide release and neurogenic inflammation differ between rat and human skin.","volume":"529","author":"Sauerstein","year":"2000","journal-title":"J Physiol"},{"key":"R31-35-20210902","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1152\/jn.1991.66.1.190","article-title":"Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms.","volume":"66","author":"LaMotte","year":"1991","journal-title":"J Neurophysiol"},{"key":"R32-35-20210902","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1523-1747.2000.00142.x","article-title":"Acute effects of substance P and calcitonin gene-related peptide in human skin: a microdialysis study.","volume":"115","author":"Weidner","year":"2000","journal-title":"J Invest Dermatol"},{"key":"R33-35-20210902","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0165-6147(00)01502-9","article-title":"NK1 (substance P) receptor antagonists: why are they not analgesic in humans?","volume":"21","author":"Hill","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"R34-35-20210902","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1213\/00000539-199912000-00039","article-title":"The effects of intradermal fentanyl and ketamine on capsaicin-induced secondary hyperalgesia and flare reaction.","volume":"89","author":"Koppert","year":"1999","journal-title":"Anesth Analg"},{"key":"R35-35-20210902","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archderm.140.11.1351","article-title":"Effect of volume and concentration on the diffusion of botulinum exotoxin A.","volume":"140","author":"Hsu","year":"2004","journal-title":"Arch Dermatol"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/01.ane.0000194447.46763.73","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:10Z","timestamp":1786112770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200602000-00035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1213\/01.ane.0000194447.46763.73","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}